The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation.
暂无分享,去创建一个
[1] E. Kieff,et al. Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation , 1997, Journal of virology.
[2] E. Kieff,et al. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation , 1996, Molecular and cellular biology.
[3] E. Kieff,et al. Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[4] Craig B. Thompson,et al. Hierarchical Control of Lymphocyte Survival , 1996, Science.
[5] E. Kieff,et al. Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[6] S. Lee,et al. CD30/TNF receptor-associated factor interaction: NF-kappa B activation and binding specificity. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[7] C. Thompson,et al. A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors. , 1996, The EMBO journal.
[8] C. Thompson,et al. CD30 Contains Two Binding Sites with Different Specificities for Members of the Tumor Necrosis Factor Receptor-associated Factor Family of Signal Transducing Proteins* , 1996, The Journal of Biological Chemistry.
[9] R. Noelle,et al. CD40 and its ligand in host defense. , 1996, Immunity.
[10] D. Baltimore,et al. TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-kappaB activation. , 1996, Genes & development.
[11] M. Kehry,et al. CD40-mediated signaling in B cells. Balancing cell survival, growth, and death. , 1996, Journal of immunology.
[12] K. Tamai,et al. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes , 1996, Nature.
[13] Mike Rothe,et al. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins , 1995, Cell.
[14] D. Goeddel,et al. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40 , 1995, Science.
[15] U. Prasad,et al. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia. , 1995, The American journal of pathology.
[16] B. Sugden,et al. Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus , 1995, Journal of virology.
[17] D. Baltimore,et al. Involvement of CRAF1, a relative of TRAF, in CD40 signaling , 1995, Science.
[18] C. Ware,et al. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family , 1995, Cell.
[19] M. Rowe,et al. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. , 1995, Oncogene.
[20] E. Kieff,et al. The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues , 1995, Journal of virology.
[21] E. Kieff,et al. Reducing the complexity of the transforming Epstein-Barr virus genome to 64 kilobase pairs , 1995, Journal of virology.
[22] M. Boguski,et al. A novel RING finger protein interacts with the cytoplasmic domain of CD40. , 1994, The Journal of biological chemistry.
[23] D. Goeddel,et al. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor , 1994, Cell.
[24] E. Kieff,et al. Epstein-Barr virus recombinant molecular genetic analysis of the LMP1 amino-terminal cytoplasmic domain reveals a probable structural role, with no component essential for primary B-lymphocyte growth transformation , 1994, Journal of virology.
[25] E. Kieff,et al. An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro , 1994, Journal of virology.
[26] E. Kieff,et al. Epstein-Barr virus recombinants from overlapping cosmid fragments , 1993, Journal of virology.
[27] E. Kieff,et al. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[28] S. Elledge,et al. The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. , 1993, Genes & development.
[29] E. Kieff,et al. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation , 1993, Journal of virology.
[30] Carol D. Laherty,et al. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. , 1992, The Journal of biological chemistry.
[31] M. Hammarskjöld,et al. Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity , 1992, Journal of virology.
[32] E. Kieff,et al. Second-site homologous recombination in Epstein-Barr virus: insertion of type 1 EBNA 3 genes in place of type 2 has no effect on in vitro infection , 1992, Journal of Virology.
[33] E. Kieff,et al. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation , 1991, Journal of virology.
[34] E. Kieff,et al. Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[35] E. Kieff,et al. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[36] W. Hammerschmidt,et al. Genetic analysis of immortalizing functions of EpsteinBarr virus in human B lymphocytes , 1989, Nature.
[37] E. Kieff,et al. Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus , 1986, Journal of virology.
[38] D. Staunton,et al. Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells , 1985, Journal of virology.
[39] E. Kieff,et al. Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein , 1984, Journal of virology.
[40] J. Robinson,et al. Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[41] G. Miller,et al. Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. , 1972, Proceedings of the National Academy of Sciences of the United States of America.
[42] J. Banchereau,et al. The CD40 antigen and its ligand. , 1994, Annual review of immunology.